Li-Hep vs. Non-Li-Hep Coated Transfer Device
Sample Comparison With Siemens® Point-of-care Device for Cardiac Troponin I Assay by Using a Heparin Coated Transfer Device vs. Non-heparin Coated Transfer Device at the Emergency Department (Validation Study 2.0)
Sponsor: Siemens Corporation, Corporate Technology
Listed as NCT04458155, this observational or N/A phase trial focuses on Acute Coronary Syndrome and Cardiac Ischemia and remains completed. Sponsored by Siemens Corporation, Corporate Technology, it has been updated 9 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Dec 2021 — Jul 2022 [monthly]
Active Not Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Recruiting
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Siemens Corporation, Corporate Technology
- VieCuri Medical Centre
For direct contact, visit the study record on ClinicalTrials.gov .